Dr. Yegorov's research aims to provide a better understanding of infectious diseases, offering insights that could lead to more effective methods of infection diagnosis and treatment. Dr. Yegorov's research focuses on three main areas:
1) Investigating pathogenic causes of respiratory infections;
2) Antimicrobial resistance in bacterial pneumonia and other related conditions;
3) Efficacy and effectiveness of vaccines against infectious diseases.

Research highlights

1    Yegorov S, Brewer A, Cyr L, et al. Hemagglutination-Inhibition Antibodies and Protection against Influenza Elicited by Inactivated and Live Attenuated Vaccines in Children. The Journal of Infectious Diseases 2024.

2    Yegorov S, Celeste DB, Gomes KB, et al. Inactivated and live-attenuated seasonal influenza vaccines boost broadly neutralizing antibodies in children. Cell Reports Medicine 2022.

3    Yegorov S, Goremykina M, Ivanova R, et al. Epidemiology, clinical characteristics, and virologic features of COVID-19 patients in Kazakhstan: A nation-wide retrospective cohort study. The Lancet Regional Health – Europe 2021.

4    Yegorov S, Joag V, Galiwango RM, et al. Schistosoma mansoni treatment reduces HIV entry into cervical CD4+ T cells and induces IFN-I pathways. Nature Communications 2019.